Neutropenia occurring after starting gabapentin for neuropathic pain.
We report a case of neutropenia occurring in a patient receiving gabapentin for neuropathic pain. Five weeks after treatment started, the patient was admitted to hospital with neutropenic sepsis. Gabapentin is widely used, and neutropenia is a rare adverse effect. This case highlights a serious and potential life-threatening complication.
Derbyshire
E
E
Rusthall Medical Centre, Nellington Road, Tunbridge Wells, Kent TN4 8UW, UK. derbyshireemma@hotmail.com
Martin
D
D
D000230:Adenocarcinoma / Q000150:complications; D000588:Amines / Q000009:adverse effects* / Q000627:therapeutic use*; D000700:Analgesics / Q000009:adverse effects* / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000150:complications; D003509:Cyclohexanecarboxylic Acids / Q000009:adverse effects* / Q000627:therapeutic use*; D000077206:Gabapentin; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced*; D010146:Pain / Q000188:drug therapy*; D010523:Peripheral Nervous System Diseases / Q000150:complications / Q000209:etiology; D018805:Sepsis / Q000139:chemically induced; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects* / Q000627:therapeutic use*
D000588:Amines; D000700:Analgesics; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin